These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 31031757)

  • 21. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
    Soria G; Ben-Baruch A
    Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy.
    Broad RV; Jones SJ; Teske MC; Wastall LM; Hanby AM; Thorne JL; Hughes TA
    Br J Cancer; 2021 Mar; 124(6):1110-1120. PubMed ID: 33398063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.
    Bott A; Erdem N; Lerrer S; Hotz-Wagenblatt A; Breunig C; Abnaof K; Wörner A; Wilhelm H; Münstermann E; Ben-Baruch A; Wiemann S
    Oncotarget; 2017 Jul; 8(27):43897-43914. PubMed ID: 28159925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stiffness-dependent MSC homing and differentiation into CAFs - implications for breast cancer invasion.
    Saxena N; Chakraborty S; Dutta S; Bhardwaj G; Karnik N; Shetty O; Jadhav S; Zafar H; Sen S
    J Cell Sci; 2024 Jan; 137(1):. PubMed ID: 38108421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.
    Escobar P; Bouclier C; Serret J; Bièche I; Brigitte M; Caicedo A; Sanchez E; Vacher S; Vignais ML; Bourin P; Geneviève D; Molina F; Jorgensen C; Lazennec G
    Oncotarget; 2015 Oct; 6(30):29034-47. PubMed ID: 26362269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the association of POSTN
    Lin S; Zhou M; Cheng L; Shuai Z; Zhao M; Jie R; Wan Q; Peng F; Ding S
    Int J Biol Macromol; 2024 May; 268(Pt 1):131560. PubMed ID: 38631570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-Bound Polysaccharides from
    Jędrzejewski T; Pawlikowska M; Sobocińska J; Wrotek S
    Cell Physiol Biochem; 2020 Jun; 54(4):615-628. PubMed ID: 32559360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer.
    Camorani S; Hill BS; Fontanella R; Greco A; Gramanzini M; Auletta L; Gargiulo S; Albanese S; Lucarelli E; Cerchia L; Zannetti A
    Theranostics; 2017; 7(14):3595-3607. PubMed ID: 28912898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of INFG/STAT1/NOTCH3 as γ-Mangostin's potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer.
    Lawal B; Wu AT; Chen CH; T A G; Wu SY
    Biomed Pharmacother; 2023 Jul; 163():114800. PubMed ID: 37141739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells.
    Wang M; Zhang J; Huang Y; Ji S; Shao G; Feng S; Chen D; Zhao K; Wang Z; Wu A
    Med Sci Monit; 2017 Aug; 23():3904-3912. PubMed ID: 28802099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis.
    Jin K; Pandey NB; Popel AS
    Breast Cancer Res; 2018 Jun; 20(1):54. PubMed ID: 29898755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment.
    Tsai TH; Yang CC; Kou TC; Yang CE; Dai JZ; Chen CL; Lin CW
    J Cell Physiol; 2021 Jun; 236(6):4669-4680. PubMed ID: 33421130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes.
    Dieters-Castator D; Dantonio PM; Piaseczny M; Zhang G; Liu J; Kuljanin M; Sherman S; Jewer M; Quesnel K; Kang EY; Köbel M; Siegers GM; Leask A; Hess D; Lajoie G; Postovit LM
    Neoplasia; 2021 Apr; 23(4):375-390. PubMed ID: 33784590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages.
    Nordin FJ; Pearanpan L; Chan KM; Kumolosasi E; Yong YK; Shaari K; Rajab NF
    PLoS One; 2021; 16(8):e0256012. PubMed ID: 34379689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity.
    Alcaraz LB; Mallavialle A; Mollevi C; Boissière-Michot F; Mansouri H; Simony-Lafontaine J; Laurent-Matha V; Chardès T; Jacot W; Turtoi A; Roger P; Guiu S; Liaudet-Coopman E
    Int J Cancer; 2023 Mar; 152(6):1243-1258. PubMed ID: 36346290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.
    Malone MK; Smrekar K; Park S; Blakely B; Walter A; Nasta N; Park J; Considine M; Danilova LV; Pandey NB; Fertig EJ; Popel AS; Jin K
    Cancer Biol Ther; 2020 Jun; 21(6):560-569. PubMed ID: 32213106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.
    Shin SY; Nam JS; Lim Y; Lee YH
    J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.